Precision medicine expands healthcare beyond oncology, reports GlobalData

New Delhi: Precision medicine, once primarily focused on oncology, is now transforming various fields of healthcare by tailoring medical treatments to individual genetic, environmental, and lifestyle factors. This personalized approach is enhancing disease prevention, diagnosis, and treatment efficacy across a range of conditions, according to a report by GlobalData, a leading data and analytics company.

Advancements in genomics, bioinformatics, and data analytics underpin the core of precision medicine. The completion of the Human Genome Project in 2003 was a pivotal milestone, providing a comprehensive map of human DNA and enabling researchers to identify genetic variations linked to specific diseases. Technological advancements, such as next-generation sequencing (NGS), have since made it feasible to sequence entire genomes quickly and affordably.

“Precision medicine can reshape disease treatments and provide better treatment options to patients. Historically, precision medicine has been used largely for oncology, but more areas of medicine are benefiting from precision medicine recently,” commented Alexandra Murdoch, Senior Medical Analyst at GlobalData.

One notable area of impact is reproductive health, where precision medicine is used throughout IVF treatment cycles. This includes biomarker screenings to aid in determining treatment paths for infertility, endometrial receptivity arrays for precise implantation timing, and genetic testing of embryos to identify genetic abnormalities.

Precision medicine is also expanding into pandemic preparedness. In California, Governor Gavin Newsom recently announced an agreement to enhance the state’s ability to prepare for and potentially prevent future pandemics through precision medicine. When used with advanced diagnostic tools for infectious diseases, it can alleviate the burdens of future pandemics through early detection, faster response, and more effective countermeasures.

“Precision medicine has made significant strides in various fields, especially oncology. If we can replicate those strides in other areas of medicine, we can improve diagnostic tools and treatment options for many different diseases and conditions,” Murdoch added.

“The future of precision medicine is promising. The ongoing research aims to expand the understanding of the genetic basis of diseases and refine treatment approaches. As technology continues to advance, precision medicine will hopefully become more accessible and could potentially transform the landscape of healthcare.”